What are two key adverse effects of tramadol and in which patient populations should caution be heightened?

• A. Serotonergic effects and seizure risk; caution in epilepsy, serotonergic meds, elderly, and CNS depressant use
• B. Constipation; no seizure risk
• C. No interactions with SSRIs
• D. Only sedation

Answer: (A)

Tramadol carries two distinct drug-action risks that stand out because of its dual mechanism: it is a weak opioid receptor agonist and also inhibits serotonin and norepinephrine reuptake. This combination makes serotonergic effects and seizure risk the most clinically important adverse effects to watch for. Serotonergic effects arise from increased serotonin in the nervous system, which can lead to serotonin syndrome—especially when tramadol is used with other serotonergic medications such as SSRIs, SNRIs, TCAs, MAO inhibitors, or certain migraine therapies. This makes caution necessary in patients who are already on serotonergic drugs or who have conditions that predispose them to serotonin toxicity.

Seizure risk is another key concern because tramadol can lower the seizure threshold. The risk is higher in individuals with a history of seizures or epilepsy, in those taking other medications that provoke seizures or reduce seizure control (for example, certain antidepressants or other CNS-active drugs), and at higher doses or with concomitant CNS depressants. Elderly patients are particularly vulnerable due to polypharmacy and age-related changes in drug handling, as well as increased sensitivity to CNS effects.

So the best answer identifies serotonergic effects and seizure risk and highlights populations where heightened caution is warranted: people with epilepsy or a history of seizures, those on serotonergic medications, older adults, and individuals using CNS depressants.